| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Vascular Biology |
From the Departments of Cardiovascular Medicine (S.J., I.S., A.K.) and Pharmacology (Y.H.), Hokkaido University School of Medicine, Sapporo, Japan.
Correspondence to Ichiro Sakuma, MD, PhD, Department of Cardiovascular Medicine, Hokkaido University School of Medicine, Sapporo 060-8638, Japan. E-mail sakuichi{at}seagreen.ocn.ne.jp
Objective Estrogen replacement therapy (ERT) ameliorates symptoms in postmenopausal women with syndrome X. We hypothesized that estrogen deprivation and replacement may modulate coronary expressions of angiogenic molecules, thereby modifying the coronary capillary network in perimenopausal women.
Methods and Results Middle-aged (40-week-old) female rats were subjected to sham surgery, ovariectomy, or ovariectomy with ERT. Using immunohistochemical and in situ hybridization techniques, we showed that protein and gene expressions of estrogen receptor ß, but not
, in coronary vessels were regulated by in vivo estrogen manipulations. Morphometric analysis showed a reduction in total coronary capillary density with decreased arteriolar capillaries after ovariectomy. ERT resulted in normalization of total capillary number with increased venular capillaries. Coronary expressions of vascular endothelial growth factor (VEGF) and its angiogenic receptor (fetal liver kinase-1) were diminished after ovariectomy, and ERT restored it to intact levels. Higher expressions of VEGF and fetal liver kinase-1 in middle-aged compared with young female rats were associated with an accumulation of hypoxia-inducible factor-1 protein, which was highly expressed in middle-aged female rats.
Conclusions The coronary capillary network in middle-aged women may be regulated by physiological angiogenesis via VEGF, and reduction in coronary VEGF expression by estrogen deficiency could play a role as a molecular pathogenesis in the development of coronary heart disease in postmenopausal women.
Key Words: angiogenesis coronary capillary network estrogen vascular endothelial growth factors middle-aged female rats
This article has been cited by other articles:
![]() |
S. Jesmin, S. Zaedi, N. Shimojo, M. Iemitsu, K. Masuzawa, N. Yamaguchi, C. N. Mowa, S. Maeda, Y. Hattori, and T. Miyauchi Endothelin antagonism normalizes VEGF signaling and cardiac function in STZ-induced diabetic rat hearts Am J Physiol Endocrinol Metab, April 1, 2007; 292(4): E1030 - E1040. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Gimenez, P. M Garcia, B. Bonacasa, L. F Carbonell, T. Quesada, and I. Hernandez Effects of oestrogen treatment and angiotensin-converting enzyme inhibition on the microvasculature of ovariectomized spontaneously hypertensive rats Exp Physiol, January 1, 2006; 91(1): 261 - 268. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Jesmin, H. Togashi, I. Sakuma, C. N. Mowa, K.-I. Ueno, T. Yamaguchi, M. Yoshioka, and A. Kitabatake Gonadal Hormones and Frontocortical Expression of Vascular Endothelial Growth Factor in Male Stroke-Prone, Spontaneously Hypertensive Rats, a Model for Attention-Deficit/Hyperactivity Disorder Endocrinology, September 1, 2004; 145(9): 4330 - 4343. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. G. Lamping, L. P. Christensen, and R. J. Tomanek Estrogen therapy induces collateral and microvascular remodeling Am J Physiol Heart Circ Physiol, November 1, 2003; 285(5): H2039 - H2044. [Abstract] [Full Text] [PDF] |
||||
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2002 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |